BLU-222 is an orally available but selective cell cycle protein-dependent kinase (CDK2) inhibitor with antitumor activity for the study of ovarian and uterine cancer.
Marketplace OffersShowing from 1 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
1-3 days
Purity
99.93%
$ 123.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.